Safety, Tolerability and Pharmacokinetic Characteristics of JYP0061 in Healthy Adult Subjects After Single and Multiple Doses: a Single-center, Randomized, Double-blind, Placebo-controlled, Phase I Trial
The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of JYP0061 in healthy adult subjects. The main questions it aims to answer are: safety and tolerability of JYP0061 in healthy subjects, the pharmacokinetic characteristics after single and multiple doses and the effect of food on the pharmacokinetic characteristics. Participants will be treated with JYP0061 orally and safety and pharmacokinetic evaluations will be conducted according to the protocol.
一项采用单中心、随机、双盲、安慰剂对照、剂量递增试验设计,评估健康成人志愿者单次和多次口服JYP0061的安全性、耐受性及药代动力学及药效学特征的临床试验。
本研究的主要目的是评估健康成人单次和多次服用JYP0061片后的安全性和耐受性。评价的主要终点指标为在规定的评估时间内不良事件、严重不良事件的发生率。
一项II期探索性临床研究评估JYP0061在视神经脊髓炎谱系疾病(NMOSD)急性期的有效性和安全性的临床试验
评估JYP0061治疗视神经脊髓炎谱系疾病(NMOSD)急性期受试者的临床有效性、安全性
100 项与 JYP-0061 相关的专利(医药)